Erratum
Utine CA. Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite®) solution in the treatment of ocular infections. Clin Ophthalmol. 2011;5:801-809.Table 2 inaccurately states that Bremond-Grignac used AzaSite® in their study. The ophthalmic pr...
Main Author: | Utine CA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-09-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/erratum---a8378 |
Similar Items
-
Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite®) solution in the treatment of ocular infections
by: Utine CA
Published: (2011-06-01) -
Erratum
by: V. Lemos, et al.
Published: (2004-06-01) -
Intracorneal ring implantation using Intralase® with partial coverage of the cone in a patient after an alkaline injury
by: Cakir H, et al.
Published: (2011-11-01) -
Erratum Erratum
by: Luiz M. Cangiani
Published: (2001-12-01) -
Genetics in Ophthalmology I - Basic Concepts
by: Canan Aslı Utine, et al.
Published: (2012-10-01)